ÂÜÀòÂÒÂ×

André Lieber is an academic researcher who has studied the biological and translational aspects of human adenoviruses for more than two decades. The Lieber lab has capitalized on mechanisms evolved by adenoviruses to establish infection and developed new approaches for the treatment of cancer using recombinant adenovirus proteins. Two of these approaches are currently being tested in cancer patients.